Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.
Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.
复制标题
DOI:
10.1016/j.jmb.2010.07.029
复制
发表时间:
2010-09-10
影响因子:
5.6
通讯作者:
Geisbrecht BV
中科院分区:
文献类型:
--
作者:
Garcia BL;Ramyar KX;Tzekou A;Ricklin D;McWhorter WJ;Lambris JD;Geisbrecht BV
The human complement system plays an essential role in innate and adaptive immunity by marking and eliminating microbial intruders. Activation of complement on foreign surfaces results in proteolytic cleavage of complement component 3 (C3) into the potent opsonin C3b, which triggers a variety of immune responses and participates in a self-amplification loop mediated by a multi-protein assembly known as the C3 convertase. The human pathogen Staphylococcus aureus has evolved a sophisticated and potent complement evasion strategy, which is predicated upon an arsenal of potent inhibitory proteins. One of these, the Staphylococcal Complement INhibitor (SCIN), acts at the level of the C3 convertase (C3bBb) and impairs downstream complement function by trapping the convertase in a stable but inactive state. Previously, we have shown that SCIN binds C3b directly and competitively inhibits binding of human factor H, and to a lesser degree that of factor B to C3b. Here, we report the co-crystal structures of SCIN bound to C3b and C3c at 7.5 and 3.5 Å limiting resolution, respectively, and show that SCIN binds a critical functional area on C3b. Most significantly, the SCIN binding site sterically occludes the binding sites of both fH and fB. Our results give insight into SCIN binding to activated derivatives of C3, explain how SCIN can recognize C3b in the absence of other complement components, and provide a structural basis for the competitive C3b-binding properties of SCIN. In the future, this may suggest templates for the design of novel complement inhibitors based upon the SCIN structure.
登录
查看更多内容
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
影响因子:
11.4
作者:
Janssen, Bert J. C.;Gomes, Lucio;Gros, Piet
通讯作者:
Gros, Piet
影响因子:
6.7
作者:
Chavakis, T;Wiechmann, K;Herrmann, M
通讯作者:
Herrmann, M
DOI:
10.1084/jem.20070818
发表时间:
2007-10-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Jongerius I;Köhl J;Pandey MK;Ruyken M;van Kessel KP;van Strijp JA;Rooijakkers SH
通讯作者:
Rooijakkers SH
影响因子:
14.9
作者:
Davis IW;Leaver-Fay A;Chen VB;Block JN;Kapral GJ;Wang X;Murray LW;Arendall WB 3rd;Snoeyink J;Richardson JS;Richardson DC
通讯作者:
Richardson DC